PRAH stock forecast
Our latest prediction for PRA Health Sciences, Inc.'s stock price was made on the April 27, 2020 when the stock price was at 89.39$.
In the short term (2weeks), PRAH's stock price should underperform the market by -0.53%. During that period the price should oscillate between -6.07% and +5.28%.
In the medium term (3months), PRAH's stock price should underperform the market by -1.25%. During that period the price should oscillate between -17.15% and +14.17%.Get email alerts
Create a solid portfolio with PRAH
About PRA Health Sciences, Inc.
PRA Health Sciences, Inc. engages in the provision of outsourced clinical development services to the biotechnology and pharmaceutical industries. It operates through Clinical Research and Data Solutions segment. The Clinical Research segment serves biopharmaceutical clients and offers outsourced clinical research and clinical trial related services. The Data Solutions segment involves in data and analytics; technology solutions and real-world insights; and services primarily to the company's life science clients. The company was founded in 1976 and is headquartered in Raleigh, NC.
At the moment the company generates 3066M USD in revenues.
On its last earning announcement, the company reported a profit of 3.68$ per share.
The book value per share is 14.72$
Three months stock forecastApril 27, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|